Evidence map›Paper›PMID 39058193›Full record

ArticleTropical medicine and infectious disease2024

Detection and Serological Evidence of European Bat Lyssavirus 1 in Belgian Bats between 2016 and 2018.

Inne Nauwelaers, Claudia Van den Eynde, Sanne Terryn, Bob Vandendriessche, Wout Willems, Daan Dekeukeleire, Steven Van Gucht

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Inne NauwelaersViral Diseases Unit, Sciensano, 1000 Brussels, Belgium.ORCID 0000-0003-3577-6776
Claudia Van den EyndeViral Diseases Unit, Sciensano, 1000 Brussels, Belgium.ORCID 0000-0003-0836-2818
Sanne TerrynViral Diseases Unit, Sciensano, 1000 Brussels, Belgium.ORCID 0000-0002-5524-9984
Bob VandendriesscheNatuurpunt Studie, Vleermuizenwerkgroep, 2800 Mechelen, Belgium.
Wout WillemsNatuurpunt Studie, Vleermuizenwerkgroep, 2800 Mechelen, Belgium.
Daan DekeukeleireNatuurpunt Studie, Vleermuizenwerkgroep, 2800 Mechelen, Belgium.ORCID 0000-0003-0664-8396
Steven Van GuchtViral Diseases Unit, Sciensano, 1000 Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lyssaviruses are neurotropic viruses capable of inducing fatal encephalitis. While rabies virus has been successfully eradicated in Belgium, the prevalence of other lyssaviruses remains uncertain. In this study, we conducted a survey on live animals and passive surveillance to investigate the presence of lyssaviruses in Belgium. In 2018, a total of 113 saliva samples and 87 blood samples were collected from bats. Saliva was subjected to RT-qPCR to identify lyssavirus infections. Additionally, an adapted lyssavirus neutralisation assay was set up for the detection of antibodies neutralising EBLV-1 in blood samples. Furthermore, we examined 124 brain tissue samples obtained from deceased bats during passive surveillance between 2016 and 2018. All saliva samples tested negative for lyssaviruses. Analysis of the blood samples uncovered the presence of lyssavirus-neutralising antibodies in five bat species and 32% of samples with a wide range depending on bat species, suggesting past exposure to a lyssavirus. Notably, EBLV-1 was detected in brain tissue samples from two

Indexed as

European bat lyssavirusPCRrabiesserologysurveillance

Identifiers

PMID39058193
PMCPMC11281572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.